Answers are grounded in this paper and cite their sources.
Purpose: Cancer treatment often exacerbates symptoms such as fatigue, insomnia, and gastrointestinal disturbances. This study aimed to provide real-world evidence of exercise on symptom control in patients undergoing cancer treatment. Methods: The analysis included patients undergoing cancer treatment, who participated in the three-month Life Now Exercise oncology program across 13 community-based sites in Western Australia. Individually tailored resistance, aerobic, and flexibility exercises at a moderate-to-high intensity were delivered twice per week in a group format, supervised by accredited exercise physiologists. Symptom burden was assessed at baseline, post-intervention, and six months post-intervention using the European Organisation for Research and Treatment of Cancer Quality-of-Life Core module (EORTC QLQ-C30) and the Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F). Results: Of 328 participants, 63% were aged under 65 years, 56% had breast cancer, 86% had localised disease, and 60% were undergoing hormonal therapy with/without additional radiotherapy and other systemic therapies. Improvements were observed at post-intervention in fatigue (EORTC: -3.3 [95% CI -5.5 to -1.1]; FACIT-F: 1.7 [95% CI 0.7 to 2.7]), insomnia (-3.6 [95% CI -6.9 to -0.3]), appetite loss (-3.2 [95% CI -5.9 to -0.5]), and financial difficulties (-2.8 [95% CI -5.5 to -0.1]), with most improvements sustained at six months post-intervention. Responses varied across breast, digestive, and genitourinary cancer subgroups and were associated with diverse demographic and clinical factors. However, meaningful improvements were consistently observed in patients with clinically relevant symptoms at baseline. Conclusions: Multimodal exercise at a moderate-to-high intensity is a promising non-pharmaceutical intervention for reducing symptom burden during cancer treatment. Similar exercise programs may be considered during cancer treatment for symptom control.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: